(Q40551481)

21 September 2017

title

Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine (English)

1 reference

21 September 2017

1 reference

Jean-Frédéric Colombel

11

object named as

J-F Colombel

1 reference

21 September 2017

B Bonaz

1

1 reference

21 September 2017

J Boitard

2

1 reference

21 September 2017

P Marteau

3

1 reference

21 September 2017

M Lémann

4

1 reference

21 September 2017

B Coffin

5

1 reference

21 September 2017

B Flourié

6

1 reference

21 September 2017

J Belaiche

7

1 reference

21 September 2017

G Cadiot

8

1 reference

21 September 2017

E-H Metman

9

1 reference

21 September 2017

A Cortot

10

1 reference

21 September 2017

Getaid

12

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Alimentary Pharmacology & Therapeutics

21 September 2017

published in

1 reference

21 September 2017

volume

18

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

401-408

1 reference

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Mechanism of azathioprine-induced injury to hepatocytes: roles of glutathione depletion and mitochondrial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Hepatic veno-occlusive disease caused by 6-thioguanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

6-thioguanine--efficacy and safety in chronic active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

Possible carcinogenic effect of 6-mercaptopurine on bone marrow stem cells: relation to thiopurine metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01683.X

10.1046/J.1365-2036.2003.01683.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference